Pacira | PCRX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Astellas Pharma JPY 188.37B 8.51B 2025-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Cara Therapeutics USD 20.73M 684K 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Heron Therapeutics USD 26.12M 2.53M 2026-03
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
J&J USD 21.69B 1.98B 2026-03
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novo Nordisk A/S DKK 18.44B 5.78B 2025-06
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 144.31M 14.24M 2026-03
Perrigo USD 531.6M 99.5M 2025-12
Pfizer USD 1.7B 561M 2026-03
Supernus Pharmaceuticals USD 184.87M 56.42M 2026-03
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xeris Pharmaceuticals USD 111.75M 708K 2026-03
Xoma USD 143.9M 7.68M 2024-06
Zoetis USD 1.94B 369M 2026-03